The National Institutes of Health and Centers for Disease Control and Prevention at the Health and Human Services Department are quickly implementing the funding provisions of the Childhood Cancer Survivorship, Treatment Access, and Research Act of 2018 (PL 115-180), which was signed into law by President Trump last summer. The STAR Act was developed in collaboration with many childhood cancer organizations and is a comprehensive, bipartisan childhood cancer bill designed to advance pediatric and adolescent/young adult cancer research and treatments, improve cancer surveillance and enhance resources for survivors and their families. Millions to advance cause A major provision of the new law is authorizing $30 million annually from FY 2019-2023 for programs and research to combat childhood cancer at NIH and CDC. Through the new law’s regulations and funding programs, NIH is: Expanding opportunities for childhood cancer research through authorizing its National Cancer Institute to increase existing [...]
Login to read the full story or Subscribe now!
2/1/19 5:34 PM